Medivir to present at the H.C. Wainwright BioConnect Virtual Conference
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright BioConnect Virtual Conference, January 10-13. The presentation will be available via Medivirs website; www.medivir.com.More information about the event is available at the organizer’s website: https://hcwevents.com/bioconnect/. For additional information, please contactMagnus Christensen, Interim CEO and CFOTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.com Medivir in briefMedivir develops innovative